A phase II clinical trial of polyethylene glycol-conjugated L-asparaginase in patients with advanced ovarian cancer: Early closure for safety
John L. Hays(The Ohio State University), Elise C. Kohn(National Cancer Institute), Nicole Houston(Johns Hopkins University), Christina M. Annunziata(National Cancer Institute), Seth M. Steinberg(National Institutes of Health), Geoff Kim(National Cancer Institute), Jennifer Squires(National Cancer Institute), Jung Min Lee(Kyung Hee University), Amanda J. Walker(National Cancer Institute)
Cited by 36
Related Papers
Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing
|Nature Communications|2018|964
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
|The Journal of Clinical Endocrinology & Metabolism|2003|650